N. Spita

Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening.

P. Giorgi Rossi, M. D'amico, D. Gustinucci, 2016, American journal of clinical pathology.

Contributor Index Vol. 51, 2007

M. Hattori, H. Kuramoto, K. Kapila, 2007, Acta Cytologica.

Role of p16INK4a Cytology Testing as an Adjunct to Enhance the Diagnostic Specificity and Accuracy in Human Papillomavirus-Positive Women within an Organized Cervical Cancer Screening Program

F. Fulciniti, M. Staiano, D. Butera, 2012, Acta Cytologica.

A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer

T. Rubeca, N. Segnan, C. Fraser, 2016, Gut.

Expression of p16 in abnormal pap-tests as an indicator of CIN2+ lesions: a possible role in the low grade ASC/US and L/SIL (Ig) cytologic lesions for screening prevention of uterine cervical tumours.

M. D'amico, D. Gustinucci, S. Bulletti, 2010, Pathologica.

Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy

P. Giorgi Rossi, M. D'amico, D. Gustinucci, 2017, Journal of medical screening.